Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Bacterial Cell Wall01:22

Bacterial Cell Wall

5.4K
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
5.4K
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

4.7K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
4.7K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

190
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
190
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

128
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
128

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Analysis of the relationship between intestinal segmented filamentous bacteria and rotavirus infection in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Same author

[The association between <i>Helicobacter pylori</i> virulence factor genotypes and gastroduodenal diseases in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2023
Same author

[The relationship between genetic polymorphism of CYP2C19 and the efficacy of <i>Helicobacter pylori</i> eradication therapy in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2023
Same author

Adipose tissue-derived mesenchymal stem cells attenuate lung inflammation and fibrosis in the bleomycin-induced pulmonary fibrosis rat model via caveolin-1/NF-kB signaling axis.

Physiological research·2022
Same author

Frederick Hiles.

British dental journal·2020
Same author

Prognostic significance of lymphovascular invasion in patients with salivary duct cell carcinoma of the head and neck.

International journal of oral and maxillofacial surgery·2019

Related Experiment Video

Updated: Apr 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K

Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.

S Fernandez-Lopez1, H S Kim, E C Choi

  • 1Present address: Departamento de Química Orgánica, Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain.

Nature
|July 27, 2001
PubMed
Summary

New cyclic peptides show potent antibacterial activity against drug-resistant bacteria. These compounds selectively target bacterial membranes, offering a promising new therapeutic strategy to combat infections and overcome antibiotic resistance.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 27, 2016

11.5K
Production and Testing of Antimicrobial Peptides and Their Mimics
10:32

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

413

Related Experiment Videos

Last Updated: Apr 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 27, 2016

11.5K
Production and Testing of Antimicrobial Peptides and Their Mimics
10:32

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

413

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • The rise of antibiotic-resistant bacterial infections necessitates novel therapeutic approaches.
  • Existing antibiotics face challenges due to resistance and limited efficacy.

Purpose of the Study:

  • To investigate the antibacterial potential of cyclic d,l-alpha-peptides.
  • To assess their selectivity towards bacterial membranes versus mammalian cells.

Main Methods:

  • Synthesized six- and eight-residue cyclic d,l-alpha-peptides.
  • Evaluated membrane permeability and ion potential changes in bacteria.
  • Tested efficacy against methicillin-resistant Staphylococcus aureus (MRSA) in a mouse model.

Main Results:

  • Cyclic d,l-alpha-peptides demonstrated preferential activity against Gram-positive and Gram-negative bacteria.
  • These peptides increased bacterial membrane permeability and collapsed transmembrane ion potentials, leading to rapid cell death.
  • High efficacy was observed in treating lethal MRSA infections in mice.

Conclusions:

  • Cyclic d,l-alpha-peptides are effective, selective antibacterial agents with potential to combat drug-resistant bacteria.
  • Their proteolytic stability and ease of synthesis make them attractive therapeutic candidates.
  • These novel peptides complement existing antibiotics and may help mitigate the development of further resistance.